Study backs pneumatic compression method:
This article was originally published in Clinica
Executive Summary
The first prospective study to evaluate intermittent pneumatic compression (IPC) as an adjunctive treatment for breast cancer-associated lymphedoema (fluid accumulation) has found it to be safe and effective. The study, conducted by researchers at the Stanford University School of Medicine, California, assessed the technique in 27 patients with lymphedoema as a consequence of surgery and radiation to treat breast cancer. Used alongside other, established decongestive lymphatic therapy, IPC provides an enhancement of patients' therapeutic response, say the researchers, whose findings appear in Cancer (December 1).